Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 19, Number 29, 2013

Articles

Favourites:
ADD

Epidemiology and Natural History of Patients with NAFLD
pp. 5169-5176(8)
Authors: Bhala, Neeraj; Ibrahim Kamal Jouness, Ramy; Bugianesi, Elisabetta

Favourites:
ADD

Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
pp. 5177-5192(16)
Authors: Lonardo, Amedeo; Sookoian, Silvia; Chonchol, Michel; Loria, Paola; Targher, Giovanni

Favourites:
ADD

Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease
pp. 5193-5218(26)
Authors: Petta, Salvatore; Handberg, Aase; Craxi, Antonio

Favourites:
ADD

Open Access Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
pp. 5219-5238(20)
Authors: Dongiovanni, Paola; M. Anstee, Quentin; Valenti, Luca

Favourites:
ADD

From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
pp. 5239-5249(11)
Authors: De Minicis, Samuele; Day, Chris; Svegliati-Baroni, Gianluca

Favourites:
ADD

Pathophysiology of NASH: Perspectives for a Targeted Treatment
pp. 5250-5269(20)
Authors: Marra, Fabio; Lotersztajn, Sophie

Favourites:
ADD

The Role of Lifestyle Change in the Prevention and Treatment of NAFLD
pp. 5270-5279(10)
Authors: Centis, Elena; Marzocchi, Rebecca; Suppini, Alessandro; Dalle Grave, Riccardo; Villanova, Nicola; J Hickman, Ingrid; Marchesini, Giulio

Favourites:
ADD

Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
pp. 5280-5296(17)
Authors: Carulli, Lucia; Maurantonio, Mauro; Hebbard, Lionel; Baldelli, Enrica; Loria, Paola; George, Jacob

Favourites:
ADD

Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients?
pp. 5297-5313(17)
Authors: Musso, Giovanni; Anty, Rodolphe; Petta, Salvatore

Favourites:
ADD

Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target
pp. 5314-5324(11)
Authors: Miele, Luca; Marrone, Giuseppe; Lauritano, Cristiano; Cefalo, Consuelo; Gasbarrini, Antonio; Day, Chris; Grieco, Antonio

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content